INS and obesity due to melanocortin 4 receptor deficiency: Epidemiological studies revealed an association between increased levels of insulin and cancer risk, including breast, pancreatic, and endometrial cancers, indicating that hyperinsulinemia may be a key risk factor for cancer in patients with obesity and diabetes.